1 October 2025

Ilika plc

("Ilika", the "Group". or the "Company")

Exercise of Options, Issue of New Ordinary Shares and Total Voting Rights

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that, following the vesting and exercise of options under the Company's share option schemes, it has issued 30,000 new ordinary shares of 1p each in the Company ("New Ordinary Shares"). Accordingly, the Company has applied to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur on or around 8.00 a.m. on 6 October 2025.

Total Voting Rights

Following Admission, the Company's issued share capital will comprise 180,832,175 Ordinary Shares and that number may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.  The Company does not hold any shares in treasury. 

For more information contact:

About Ilika plc - https://www.ilika.com

Ilika is a global expert in the development of solid state battery technology for electric vehicles, medical devices and consumer appliances. The Company's pioneering next-generation technologies aim to provide scalable, affordable alternatives to conventional batteries, to industries which need to incorporate a smaller, lighter, and safer power source in their products.

The Company has two product lines. Its Stereax batteries are designed for powering miniature medical implants, industrial wireless sensors and Internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

Through its licensing business model, Ilika supplies its IP portfolio to both OEMs and manufacturing partners in exchange for a license fee and future royalties